Want to hear the latest developments regarding Tetra’s hepatocellular carcinoma drug?
Responsible for 80% of primary malignant liver tumours in adults, hepatocellular carcinoma is a common form of liver cancer – but did you know...
Ketamine may hold potential as treatment for autism and Tourette’s
To this day there is no known cure for either autism or Tourette’s syndrome, however, new research has revealed how a common anaesthetic could...
Nerve pain drug could help restore limb function after spinal cord injury
A mouse study has shown that nerve pain drug gabapentin promotes regeneration of neural circuits.
New research in mice suggests that long-term treatment with gabapentin,...
World’s first magic mushroom nasal spray for PTSD and depression
PTSD and depression are two conditions that are being trialled for treatment with psilocybin.
A ‘magic mushroom’ nasal spray has been designed to make microdosing...
Clinical trials: FDA marks psilocybin for depression treatment
The FDA designation represents a major step forward in mental health research and for patients suffering from depression.
A non-profit medical research centre, the Usona...
New antibiotic on the horizon to combat drug resistance
Today, more and more bacterial pathogens of infectious diseases are becoming resistant to customary antibiotics.
A new discovery, from an international team of researchers, with...
Crohn’s disease: how associated bacteria develop drug resistance
Many patients with Crohn's disease develop resistance to treatments.
Researchers have looked at how Chron’s disease-related bacteria can form drug resistance.
They found that bacteria associated...
Why veterinarians should be at the heart of the drug resistance fightback
When antibiotic resistance could be responsible for up to 10 million deaths a year by 2050 if left unchecked, it is natural to want...
General Election manifesto for UK pharmaceutical industry launched
The Association of the British Pharmaceutical Industry has launched its General Election 2020 Manifesto for Medicine.
The UK pharmaceutical industry body is calling on all...
Gene patent reform in the US and the knock-on effect in Europe
Rosie McDowell, an attorney at EIP shares her thoughts on gene patent reform and the potential impact it might have across the globe.
This year...
Structure of a novel enzyme linked to cell growth and cancer cracked
A new UC Riverside-led study could lead to the development of drugs that target liver and other cancers.
RNA, or ribonucleic acid, is present in...
Snail venom to pain relief: how conotoxins can be used in pain therapy
Conotoxins, found in the venom of the one of the sea’s deadliest creatures, the cone snail, have the potential to become a new class...
Could lenalidomide delay the onset of myeloma-related bone, organ damage?
According to the Eastern Cooperative Oncology Group, lenalidomide, a cancer drug, may delay the onset of bone and other myeloma-related organ damage.
Published in the...
Oral cholera vaccine: IVI awarded $4.5 million grant to increase accessibility
The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to increase accessibility of oral cholera...
C difficile infection: The search for new Clostridioides difficile vaccine
University of Exeter researchers have made a breakthrough in the quest for a new vaccine for killer hospital bug Clostridioides difficile (C difficile infection).
The...
Clarithromycin resistance has doubled in two decades
Clarithromycin resistance – a commonly-used antibiotic for treating harmful bacteria related to a variety of stomach conditions – has more than doubled in 20...
Tetra Bio-Pharma: global developer of cannabinoid-derived products
Dr Guy Chamberland explains how Tetra Bio-Pharma is taking a pharmaceutical pathway to discovering and developing cannabinoid-derived products.
In an industry that could aptly be...
Survey shows menopausal women being prescribed ‘inappropriate’ antidepressants
Nearly 40% of menopausal women are being prescribed antidepressants to help manage their symptoms, despite four out of five describing the treatment as ‘inappropriate.’
According...
Scientists discover new antibiotic in tropical Mexican forest
An antibiotic produced by a soil bacterium has been discovered in a Mexican tropical forest that may help lead to a "plant probiotic," more...
Novel compound can interrupt malaria parasite’s lifecycle
Scientists have proven that a novel compound inhibits key enzymes to interrupt the malaria parasite's lifecycle in human organisms and prevents transmission to vector...
